ArticlePulmonary circulation2026
LIN28B Aggravates the Inflammation in Sepsis-Induced Lung Injury by Stabilizing GATA6 mRNA and Upregulating TRAF6.
Article in Pulmonary circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LIN28B Aggravates the Inflammation in Sepsis-Induced Lung Injury by Stabilizing GATA6 mRNA and Upregulating TRAF6.Pulmonary circulation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis affects more than 19 million people globally each year, and approximately 50% of sepsis patients develop lung injury. Sepsis-triggered lung injury is characterized by over-activation of inflammatory response and the production of large amounts of inflammatory cytokines. However, the underlying mechanisms remain unclear. A cellular model of sepsis-induced lung injury was constructed using lipopolysaccharide (LPS)-exposed human pulmonary microvascular endothelial cells (HPMECs). Cell viability was checked with CCK-8. Apoptosis was checked utilizing flow cytometry and TUNEL staining. TNF-α, IL-1β, and IL-6 levels were measured through ELISA assay. Intermolecular interaction relationships were confirmed by chromatin immunoprecipitation (ChIP), RNA immunoprecipitation (RIP), RNA pull down, and dual luciferase reporter assays. LIN28B was increased in the LPS-induced HPMEC. LIN28B knockdown alleviated inflammation and cell injury in LPS-induced HPMEC. LIN28B was bound to GATA6 mRNA and enhanced its mRNA stability, consequently exacerbating LPS-triggered HPMEC inflammation and injury. GATA6 transcriptionally upregulated TRAF6 to promote LPS-induced HPMEC inflammation and injury. The manipulation of the GATA6/TRAF6 axis by LIN28B amplified inflammation and injury in HPMEC prompted by LPS. Our results revealed that LIN28B induced sepsis-triggered lung injury by stabilizing GATA6 mRNA and increasing TRAF6 expression, which might provide novel therapeutic targets for the treatment of sepsis-mediated lung injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.